BRIEF published on 06/08/2026 at 07:05, 1 month 10 days ago ADOCIA presents promising results for BioChaperone® Lispro Positive Results Phase 3 Type 2 Diabetes BioChaperone Lispro Blood Glucose Control
BRIEF published on 06/08/2026 at 07:05, 1 month 10 days ago Adocia's BioChaperone® Lispro: Promising Phase 3 Results Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro Glycemic Control
PRESS RELEASE published on 06/08/2026 at 07:00, 1 month 10 days ago Inside Information / Other news releases Adocia announces positive Phase 3 results of BioChaperone® Lispro for type 2 diabetes, presenting superior glycemic control benefits over Humalog® Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro ADA 86th Scientific Session
BRIEF published on 04/21/2026 at 20:35, 2 months 27 days ago Adocia Reports 2025 Financial Results and Strategic Developments Corporate Governance Financial Results 2025 Biopharmaceutical Advancements BioChaperone® Technology Partnerships And Patents
PRESS RELEASE published on 04/21/2026 at 20:30, 2 months 27 days ago Inside Information / News release on accounts, results ADOCIA announces full year 2025 financial results, highlights positive Phase 3 results for diabetes treatment, and secures cash runway until Q2 2027. Company advancements in key technology platforms showcased Financial Results Diabetes Treatment Phase 3 Results ADOCIA Technology Platforms
BRIEF published on 04/21/2026 at 19:35, 2 months 27 days ago ADOCIA concludes a financial agreement with Vester Finance Treasury Funding Biopharmaceutical ADOCIA Vester Finance
BRIEF published on 04/21/2026 at 19:35, 2 months 27 days ago ADOCIA Secures €6 Million Shareholder Loan from Vester Finance Shareholder Loan Cash Runway ADOCIA BioChaperone® Vester Finance
PRESS RELEASE published on 04/21/2026 at 19:30, 2 months 27 days ago Inside Information / Other news releases Adocia secures €6.0 million shareholder loan from Vester Finance, extending cash runway until Q2 2027. Funds for BioChaperone and AdoXLong development Shareholder Loan ADOCIA Vester Finance Cash Runway Extension BioChaperone
BRIEF published on 12/08/2025 at 19:35, 7 months 10 days ago ADOCIA Announces Share and Voting Rights Update Voting Rights Shares Financial Disclosure Diabetes Treatment ADOCIA
PRESS RELEASE published on 12/08/2025 at 19:30, 7 months 10 days ago Inside Information / Other news releases Adocia SA releases total number of shares and voting rights as of December 8th, 2025. Company focuses on innovative therapeutic solutions for diabetes and obesity Voting Rights Shares Diabetes Obesity ADOCIA
Published on 07/17/2026 at 15:00, 1 day 13 hours ago Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 1 day 14 hours ago Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 1 day 15 hours ago Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 2 days 3 hours ago RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 2 days 4 hours ago LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
Published on 07/18/2026 at 08:00, 20 hours 40 minutes ago Northern Data AG – Changes to the Supervisory Board and the Management Board
Published on 07/17/2026 at 20:35, 1 day 8 hours ago Farizon Opens Global Spare Part Distribution Center to Strengthen International Aftersales Support
Published on 07/17/2026 at 18:55, 1 day 9 hours ago CGTN: China vows to make AI a driver for shared prosperity amid widening AI divide
Published on 07/17/2026 at 18:32, 1 day 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/17/2026 at 18:31, 1 day 10 hours ago Disclosure of transactions in own shares from July 13 to July 17, 2026
Published on 07/17/2026 at 18:00, 1 day 10 hours ago Information regarding compliance with gender balance rules within the Board of Directors
Published on 07/17/2026 at 17:45, 1 day 10 hours ago Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
Published on 07/16/2026 at 18:08, 2 days 10 hours ago Aéroports de Paris S.A - June and half-year 2026 traffic figures
